Pharmacometabolomics applied to low-dose interleukin-2 treatment in amyotrophic lateral sclerosis.

Autor: Alarcan H; Service de Biochimie et Biologie Moléculaire, CHRU Bretonneau, Tours, France.; UMR 1253 iBrain, Université de Tours, Inserm, Tours, France., Bruno C; Service de Pharmacologie Médicale, CHRU Bretonneau, Tours, France., Emond P; UMR 1253 iBrain, Université de Tours, Inserm, Tours, France.; Laboratoire de Médecine nucléaire in vitro, CHRU Bretonneau, Tours, France., Raoul C; INM, University of Montpellier, INSERM, Montpellier, France.; ALS Reference Center, University of Montpellier, CHU Montpellier, Montpellier, France., Vourc'h P; Service de Biochimie et Biologie Moléculaire, CHRU Bretonneau, Tours, France.; UMR 1253 iBrain, Université de Tours, Inserm, Tours, France., Corcia P; UMR 1253 iBrain, Université de Tours, Inserm, Tours, France.; Service de Neurologie, CHRU Bretonneau, Tours, France., Camu W; INM, University of Montpellier, INSERM, Montpellier, France.; ALS Reference Center, University of Montpellier, CHU Montpellier, Montpellier, France., Veyrune JL; Institute of Human Genetics, University of Montepllier, Montpellier, France., Garlanda C; Department of Biomedical Sciences, Humanitas University, Milan, Italy.; IRCCS Humanitas Research Hospital, Rozzano, Italy., Locati M; IRCCS Humanitas Research Hospital, Rozzano, Italy., Juntas-Morales R; Neuromuscular Diseases Unit, European Reference Network on Rare Neuromuscular Diseases (ERN EURO-NMD), Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain., Saker S; Genethon, DNA and Cell bank, Evry, France., Suehs C; Laboratoire de Biostatistique, Epidémiologie clinique, Santé Publique, Innovation et Méthodologie (BESPIM), Université de Nîmes, Nîmes, France., Masseguin C; Delegation for Clinical Research and Innovation, Nîmes University Hospital, Nîmes, France., Kirby J; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK., Shaw P; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK., Malaspina A; UCL Queen Square Motor Neuron Disease Centre, UCL Queen Square Institute of Neurology, University College London, Queen Square, London, UK., De Vos J; Department of Cell and Tissue Engineering, University Montpellier, CHU Montpellier, Montpellier, France., Al-Chalabi A; Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK., Leigh PN; Brighton and Sussex Medical School, Brighton, UK., Tree T; Department of Computer Science, University of Sheffield, Sheffield, UK., Bensimon G; Laboratoire de Biostatistique, Epidémiologie clinique, Santé Publique, Innovation et Méthodologie (BESPIM), Université de Nîmes, Nîmes, France., Blasco H; Service de Biochimie et Biologie Moléculaire, CHRU Bretonneau, Tours, France.; UMR 1253 iBrain, Université de Tours, Inserm, Tours, France.

Publikováno v: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2024 Jun; Vol. 1536 (1), pp. 82-91. Date of Electronic Publication: 2024 May 21.

THEORY OF DISCRETE MUCKENHOUPT WEIGHTS AND DISCRETE RUBIO DE FRANCIA EXTRAPOLATION THEOREMS

Autor: Saker, S. H., Agarwal, R. P.

Publikováno v: Applicable Analysis and Discrete Mathematics, 2021 Oct 01. 15(2), 295-316.

Externí odkaz: https://www.jstor.org/stable/27090831

Generation of iPSC lines from three Laing distal myopathy patients with a recurrent MYH7 p.Lys1617del variant.

Autor: Clayton JS; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia. Electronic address: joshua.clayton@perkins.org.au., Vo C; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia., Crane J; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia., Scriba CK; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia; Neurogenetics Laboratory, Department of Diagnostic Genomics, PP Block, QEII Medical Centre, Nedlands, WA, Australia., Saker S; Genethon, DNA and Cell Bank, 91000 Evry, France., Larmonier T; Genethon, DNA and Cell Bank, 91000 Evry, France., Malfatti E; APHP, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Henri Mondor Hospital, France; Université Paris Est, U955, INSERM, IMRB, F-94010 Créteil, France., Romero NB; Sorbonne Université, Myology Institute, Neuromuscular Morphology Unit, Center for Research in Myology, GH Pitié-Salpêtrière, Paris, France; Centre de Référence de Pathologie Neuromusculaire Paris-Est, GHU Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France., Ravenscroft G; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia., Laing NG; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia., Taylor RL; Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands, WA, Australia; Centre for Medical Research, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia.

Publikováno v: Stem cell research [Stem Cell Res] 2024 Oct; Vol. 80, pp. 103491. Date of Electronic Publication: 2024 Jul 09.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.